Clinical trials: Stage IIB Non-Small Cell Lung Cancer

Recurrent Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer

Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

• Terminated
• Age: All ages
• Phase 1
• Injection or infusion
• Surgery or procedure

This phase I trial studies the side effects and best dose of radiation therapy when given together with cisplatin and etoposide in treating patients with non-small cell lung cancer that cannot be removed by surgery.

Conditions

Recurrent Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer

Trial name

NCT01411098

Testing

3-dimensional conformal radiation therapy, intensity-modulated radiation therapy, cisplatin

Where

United States

Volunteers

6 people

Sponsor

University of Washington